Swapnil P. Borse

Sarkhej Gandhinagar Highway
Ahmedabad, GJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial.

Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial.

Journal: Frontiers in medicine

Published: April 11, 2026

Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of Asparagus racemosus extracts and Shatavarin IV.

Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of Asparagus racemosus extracts and Shatavarin IV.

Journal: Frontiers in microbiology

Published: August 14, 2024

Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.

Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.

Journal: Virology journal

Published: April 07, 2023

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb-drug interactions in the management of COVID-19.

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb-drug interactions in the management of COVID-19.

Journal: Frontiers in pharmacology

Published: June 20, 2022

Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.

Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.

Journal: Frontiers in medicine

Published: March 03, 2022

Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.

Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.

Journal: Frontiers in medicine

Published: August 20, 2021

Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.

Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.

Journal: Journal of Ayurveda and integrative medicine

Published: March 06, 2021

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management.

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management.

Journal: Frontiers in pharmacology

Published: October 30, 2020

Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.

Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.

Journal: PloS one

Published: June 19, 2020

Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives.

Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives.

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Published: January 17, 2020

Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.

Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.

Journal: Journal of ethnopharmacology

Published: November 29, 2019

Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.

Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.

Journal: Pathology, research and practice

Published: June 28, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026